Stock SYMBA SYMBOLLON PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Symbollon Pharmaceuticals Inc.

Equities

SYMBA

US87151H1068

Biotechnology & Medical Research

Delayed OTC Bulletin Board
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Symbollon Pharmaceuticals Inc. -.--% -.--%

Managers

Managers TitleAgeSince
Jack H. Kessler FOU
 Founder 72 86-06-30
Paul C. Desjourdy CEO
 Chief Executive Officer 61 93-08-31

Members of the board

Members of the board TitleAgeSince
Paul C. Desjourdy CEO
 Chief Executive Officer 61 93-08-31
Jack H. Kessler FOU
 Founder 72 86-06-30
Eugene Lieberstein BRD
 Director/Board Member 84 97-12-31
Richard F. Maradie BRD
 Director/Board Member 75 97-12-31
James C. Richards BRD
 Director/Board Member 75 91-04-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 43,656,673 41,590,006 ( 95.27 %) 0 95.27 %

Company contact information

Symbollon Pharmaceuticals, Inc.

99 West Street Suite J

02052, Medfield

+

address Symbollon Pharmaceuticals Inc.(SYMBA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+16.50% 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+21.49% 116B
ARGENX SE Stock argenx SE
+22.18% 27.03B
BIONTECH SE Stock BioNTech SE
-21.35% 20.36B
GENMAB A/S Stock Genmab A/S
-16.89% 16.43B
BEIGENE, LTD. Stock BeiGene, Ltd.
-18.53% 15.91B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-44.74% 15.6B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+62.13% 14.94B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.37% 13.59B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. SYMBA Stock
  4. Company Symbollon Pharmaceuticals Inc.